Transcripts

Bristol Myers Squibb (BMY) earnings call transcripts

Every Bristol Myers Squibb earnings call Gloomberb has transcribed, with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as broad-based growth and pipeline de-risking, while calling delayed event-driven readouts encouraging rather than setbacks.

    Jul 30, 2026Confident0.78